RFC
AGIO icon

Regions Financial Corp’s Agios Pharmaceuticals AGIO Stock Holding History

Regions Financial Corp’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11
Closed -$1K – 842
2019
Q1 		$1K Hold
11
– – ﹤0.01% 1827
2018
Q4 		$1K Hold
11
– – ﹤0.01% 1797
2018
Q3 		$1K Sell
11
-5
-31% -$402 ﹤0.01% 1888
2018
Q2 		$1K Buy
+16
New +$1.4K ﹤0.01% 1973
2018
Q1 		– Sell
-100
Closed -$6K – 1967
2017
Q4 		$6K Buy
+100
New +$6.29K ﹤0.01% 1763

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Regions Financial Corp's AGIO Position: Q2 2019 in Review

Regions Financial Corp sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 11 shares — an estimated $1K sold.

Regions Financial Corp first reported a position in AGIO in Q4 2017 and held it in 5 quarters. The position peaked at $6K in Q4 2017. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Regions Financial Corp reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 11 Agios Pharmaceuticals shares in Q2 2019, an estimated $1K.
  • Regions Financial Corp first reported a position in Agios Pharmaceuticals in Q4 2017 and held it in 5 quarters.
  • Regions Financial Corp's Agios Pharmaceuticals position peaked at $6K in Q4 2017.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.